Latest Series A Funding Rounds
Companies raising their first major institutional growth round, from the product they sell to the investors backing their next stage.
- Rounds
- 878 All time
- Disclosed funding
- $34.1B 792 disclosed amounts
- Median round
- $20M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| S Science4BeautyCompany profile A Polish skincare company using a recombinant conotoxin active ingredient in anti-wrinkle creams and other products sold directly to consumers and through aesthetic-medicine channels. A Polish skincare company using a recombinant conotoxin active ingredient in anti-wrinkle creams and other products sold directly to consumers and through aesthetic-medicine channels. | PLN 7M | Series A | Biotech | Poland | Investors | |
| A AUDERCompany profile Smartphone-based shipment inspection software that connects food suppliers' dispatch records with receiving warehouses. Smartphone-based shipment inspection software that connects food suppliers' dispatch records with receiving warehouses. | ¥450M | Series A first closeSeries A | Enterprise software | Japan | Investors | |
| S SirdabCompany profile Sirdab connects businesses with warehouse and transport capacity across Saudi Arabia and the GCC, while helping providers and shippers coordinate inventory, orders and service quality. Sirdab connects businesses with warehouse and transport capacity across Saudi Arabia and the GCC, while helping providers and shippers coordinate inventory, orders and service quality. | $10M | Series A | Logistics | Saudi Arabia | Investors | |
| C CradlewiseCompany profile Cradlewise makes smart cribs that monitor infant sleep and provide soothing intended to help babies settle and stay asleep. Cradlewise makes smart cribs that monitor infant sleep and provide soothing intended to help babies settle and stay asleep. | $12M | Series A | Consumer | — | Investors | |
| W WaferCompany profile Wafer runs AI inference infrastructure that adapts a model-serving stack to each customer's workload. It benchmarks and tunes models, engines, kernels and available hardware together, then keeps optimizing live serving for latency, reliability and cost as traffic changes. Wafer runs AI inference infrastructure that adapts a model-serving stack to each customer's workload. It benchmarks and tunes models, engines, kernels and available hardware together, then keeps optimizing live serving for latency, reliability and cost as traffic changes. | $40M | Series A | Hardware | United States | Investors | |
| BN Business Nextgen Finance Private LimitedCompany profile Business Nextgen Finance is a non-bank lender providing secured credit to underserved small businesses in India. Business Nextgen Finance is a non-bank lender providing secured credit to underserved small businesses in India. | ₹2.2B | Series A | Fintech | India | Investors | |
| ST SiccaNova TherapeuticsCompany profile A biotechnology company developing an oral drug candidate for dry mouth and related gland-function disorders. A biotechnology company developing an oral drug candidate for dry mouth and related gland-function disorders. | ¥1.3B | Series A | Biotech | Japan | Investors | |
| Kn Kimi no Tonari, Inc.Company profile The developer of Uratchi, an AI fortune-telling app offering personalized relationship guidance and chat readings. The developer of Uratchi, an AI fortune-telling app offering personalized relationship guidance and chat readings. | Undisclosed | Series A | AI | Japan | Investors | |
| TT Typewriter TherapeuticsCompany profile Typewriter Therapeutics is developing an all-RNA gene-writing platform that inserts therapeutic genes at a defined genomic site without viral vectors or double-strand DNA breaks. Its programs target in vivo engineered CAR-T cells and gene insertion for severe genetic diseases, including liver disorders. Typewriter Therapeutics is developing an all-RNA gene-writing platform that inserts therapeutic genes at a defined genomic site without viral vectors or double-strand DNA breaks. Its programs target in vivo engineered CAR-T cells and gene insertion for severe genetic diseases, including liver disorders. | $56M | Series A | Biotech | United States | Investors | |
| PI PeopleX, Inc.Company profile An enterprise AI software provider offering recruiting interviews, role-play training and employee conversations. An enterprise AI software provider offering recruiting interviews, role-play training and employee conversations. | ¥5.5B | Series A | AI | Japan | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1Y Combinator (YC)
Clueso, Santé, Flai
52rounds0led - 2Andreessen Horowitz (a16z)
Eka Robotics, TypeSafe AI, Sharp Performance
29rounds9led - 3General Catalyst
Baba, Melius, Disha (formerly Curelink)
24rounds1led - 4Lightspeed
Warp Sciences, Zenzap, Avarra
21rounds4led - 5Alumni Ventures
Chariot Claims, RegCell, Inc., Lightfield
21rounds0led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.